-
Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprints. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-14 Ze-Rong Cai,Wen Wang,Di Chen,Hao-Jie Chen,Yan Hu,Xiao-Jing Luo,Yi-Ting Wang,Yi-Qian Pan,Hai-Yu Mo,Shu-Yu Luo,Kun Liao,Zhao-Lei Zeng,Shan-Shan Li,Xin-Yuan Guan,Xin-Juan Fan,Hai-Long Piao,Rui-Hua Xu,Huai-Qiang Ju
Early detection is warranted to improve prognosis of gastric cancer (GC) but remains challenging. Liquid biopsy combined with machine learning will provide new insights into diagnostic strategies of GC. Lipid metabolism reprogramming plays a crucial role in the initiation and development of tumors. Here, we integrated the lipidomics data of three cohorts (n = 944) to develop the lipid metabolic landscape
-
APOE from astrocytes restores Alzheimer's Aβ-pathology and DAM-like responses in APOE deficient microglia. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-11 Pranav Preman,Daan Moechars,Emre Fertan,Leen Wolfs,Lutgarde Serneels,Disha Shah,Jochen Lamote,Suresh Poovathingal,An Snellinx,Renzo Mancuso,Sriram Balusu,David Klenerman,Amaia M Arranz,Mark Fiers,Bart De Strooper
The major genetic risk factor for Alzheimer's disease (AD), APOE4, accelerates beta-amyloid (Aβ) plaque formation, but whether this is caused by APOE expressed in microglia or astrocytes is debated. We express here the human APOE isoforms in astrocytes in an Apoe-deficient AD mouse model. This is not only sufficient to restore the amyloid plaque pathology but also induces the characteristic transcriptional
-
JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-09 Karoline Strobl,Jörg Klufa,Regina Jin,Lena Artner-Gent,Dana Krauß,Philipp Novoszel,Johanna Strobl,Georg Stary,Igor Vujic,Johannes Griss,Martin Holcmann,Matthias Farlik,Bernhard Homey,Maria Sibilia,Thomas Bauer
The hair follicle stem cell niche is an immune-privileged microenvironment, characterized by reduced antigen presentation, thus shielding against permanent immune-mediated tissue damage. In this study, we demonstrated the protective role of hair follicle-specific epidermal growth factor receptor (EGFR) against scarring hair follicle destruction. Mechanistically, disruption of EGFR signaling generated
-
Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-09 Joseph S Durgin,Sunny Y Wong
-
Rett syndrome: interferon-γ to the rescue? EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-04 Richard R Meehan,Sari Pennings
-
Fibrolytic vaccination against ADAM12 reduces desmoplasia in preclinical pancreatic adenocarcinomas. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-30 Jing Chen,Michal Sobecki,Ewelina Krzywinska,Kevin Thierry,Mélissa Masmoudi,Shunmugam Nagarajan,Zheng Fan,Jingyi He,Irina Ferapontova,Eric Nelius,Frauke Seehusen,Dagmar Gotthardt,Norihiko Takeda,Lukas Sommer,Veronika Sexl,Christian Münz,David DeNardo,Ana Hennino,Christian Stockmann
A hallmark feature of pancreatic ductal adenocarcinoma (PDAC) is massive intratumoral fibrosis, designated as desmoplasia. Desmoplasia is characterized by the expansion of cancer-associated fibroblasts (CAFs) and a massive increase in extracellular matrix (ECM). During fibrogenesis, distinct genes become reactivated specifically in fibroblasts, e.g., the disintegrin metalloprotease, ADAM12. Previous
-
Aberrant fragmentomic features of circulating cell-free mitochondrial DNA as novel biomarkers for multi-cancer detection. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-30 Yang Liu,Fan Peng,Siyuan Wang,Huanmin Jiao,Miao Dang,Kaixiang Zhou,Wenjie Guo,Shanshan Guo,Huanqin Zhang,Wenjie Song,Jinliang Xing
Fragmentomic features of circulating cell free mitochondrial DNA (ccf-mtDNA) including fragmentation profile, 5' end base preference and motif diversity are poorly understood. Here, we generated ccf-mtDNA sequencing data of 1607 plasma samples using capture-based next generation sequencing. We firstly found that fragmentomic features of ccf-mtDNA were remarkably different from those of circulating
-
Reciprocal inhibition of NOTCH and SOX2 shapes tumor cell plasticity and therapeutic escape in triple-negative breast cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-30 Morgane Fournier,Joaquim Javary,Vincent Roh,Nadine Fournier,Freddy Radtke
Cancer cell plasticity contributes significantly to the failure of chemo- and targeted therapies in triple-negative breast cancer (TNBC). Molecular mechanisms of therapy-induced tumor cell plasticity and associated resistance are largely unknown. Using a genome-wide CRISPR-Cas9 screen, we investigated escape mechanisms of NOTCH-driven TNBC treated with a gamma-secretase inhibitor (GSI) and identified
-
Luteolin detoxifies DEHP and prevents liver injury by degrading Uroc1 protein in mice. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-29 Huiting Wang,Ziting Zhao,Mingming Song,Wenxiang Zhang,Chang Liu,Siyu Chen
Di-(2-ethylhexyl) phthalate (DEHP), an environmental pollutant, has been widely detected in both environmental and clinical samples, representing a serious threat to the homeostasis of the endocrine system. The accumulation of DEHP is notably pronounced in the liver and can lead to liver damage. The lack of effective high-throughput screening system retards the discovery of such drugs that can specifically
-
Liver DE(HP)toxification: luteolin as "phthalates-cleaner" to protect from environmental pollution. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-29 Federica Cappelli,Alessandro Mengozzi
-
Sepsis-induced changes in pyruvate metabolism: insights and potential therapeutic approaches. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-28 Louise Nuyttens,Jolien Vandewalle,Claude Libert
Sepsis is a heterogeneous syndrome resulting from a dysregulated host response to infection. It is considered as a global major health priority. Sepsis is characterized by significant metabolic perturbations, leading to increased circulating metabolites such as lactate. In mammals, pyruvate is the primary substrate for lactate production. It plays a critical role in metabolism by linking glycolysis
-
Ependymal cell lineage reprogramming as a potential therapeutic intervention for hydrocephalus. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-28 Konstantina Kaplani,Maria-Eleni Lalioti,Styliani Vassalou,Georgia Lokka,Evangelia Parlapani,Georgios Kritikos,Zoi Lygerou,Stavros Taraviras
Hydrocephalus is a common neurological condition, characterized by the excessive accumulation of cerebrospinal fluid in the cerebral ventricles. Primary treatments for hydrocephalus mainly involve neurosurgical cerebrospinal fluid diversion, which hold high morbidity and failure rates, highlighting the necessity for the discovery of novel therapeutic approaches. Although the pathophysiology of hydrocephalus
-
Epigenetic regulation by polycomb repressive complex 1 promotes cerebral cavernous malformations. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-14 Van-Cuong Pham,Claudia Jasmin Rödel,Mariaelena Valentino,Matteo Malinverno,Alessio Paolini,Juliane Münch,Candice Pasquier,Favour C Onyeogaziri,Bojana Lazovic,Romuald Girard,Janne Koskimäki,Melina Hußmann,Benjamin Keith,Daniel Jachimowicz,Franziska Kohl,Astrid Hagelkruys,Josef M Penninger,Stefan Schulte-Merker,Issam A Awad,Ryan Hicks,Peetra U Magnusson,Eva Faurobert,Massimiliano Pagani,Salim Abdelilah-Seyfried
Cerebral cavernous malformations (CCMs) are anomalies of the cerebral vasculature. Loss of the CCM proteins CCM1/KRIT1, CCM2, or CCM3/PDCD10 trigger a MAPK-Krüppel-like factor 2 (KLF2) signaling cascade, which induces a pathophysiological pattern of gene expression. The downstream target genes that are activated by KLF2 are mostly unknown. Here we show that Chromobox Protein Homolog 7 (CBX7), component
-
Unraveling autophagic imbalances and therapeutic insights in Mecp2-deficient models. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-14 Alessandro Esposito,Tommaso Seri,Martina Breccia,Marzia Indrigo,Giuseppina De Rocco,Francesca Nuzzolillo,Vanna Denti,Francesca Pappacena,Gaia Tartaglione,Simone Serrao,Giuseppe Paglia,Luca Murru,Stefano de Pretis,Jean-Michel Cioni,Nicoletta Landsberger,Fabrizia Claudia Guarnieri,Michela Palmieri
Loss-of-function mutations in MECP2 are associated to Rett syndrome (RTT), a severe neurodevelopmental disease. Mainly working as a transcriptional regulator, MeCP2 absence leads to gene expression perturbations resulting in deficits of synaptic function and neuronal activity. In addition, RTT patients and mouse models suffer from a complex metabolic syndrome, suggesting that related cellular pathways
-
Targeting USP11 regulation by a novel lithium-organic coordination compound improves neuropathologies and cognitive functions in Alzheimer transgenic mice. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-11 Yi Guo,Chuanbin Cai,Bingjie Zhang,Bo Tan,Qinmin Tang,Zhifeng Lei,Xiaolan Qi,Jiang Chen,Xiaojiang Zheng,Dan Zi,Song Li,Jun Tan
Alzheimer's Disease (AD), as the most common neurodegenerative disease worldwide, severely impairs patients' cognitive functions. Although its exact etiology remains unclear, the abnormal aggregations of misfolded β-amyloid peptide and tau protein are considered pivotal in its pathological progression. Recent studies identify ubiquitin-specific protease 11 (USP11) as the key regulator of tau deubiquitination
-
Troubling bonds: lipid unsaturation promotes selenium dependency and sensitivity to ferroptosis. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-07 Ancély Ferreira Dos Santos,José Pedro Friedmann-Angeli
-
Jag1 insufficiency alters liver fibrosis via T cell and hepatocyte differentiation defects. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-02 Jan Mašek,Iva Filipovic,Noémi Van Hul,Lenka Belicová,Markéta Jiroušková,Daniel V Oliveira,Anna Maria Frontino,Simona Hankeova,Jingyan He,Fabio Turetti,Afshan Iqbal,Igor Červenka,Lenka Sarnová,Elisabeth Verboven,Tomáš Brabec,Niklas K Björkström,Martin Gregor,Jan Dobeš,Emma R Andersson
Fibrosis contributes to tissue repair, but excessive fibrosis disrupts organ function. Alagille syndrome (ALGS, caused by mutations in JAGGED1) results in liver disease and characteristic fibrosis. Here, we show that Jag1Ndr/Ndr mice, a model for ALGS, recapitulate ALGS-like fibrosis. Single-cell RNA-seq and multi-color flow cytometry of the liver revealed immature hepatocytes and paradoxically low
-
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-02 Jessica P Wiseman,Joseph M Scarrott,João Alves-Cruzeiro,Afshin Saffari,Cedric Böger,Evangelia Karyka,Emily Dawes,Alexandra K Davies,Paolo M Marchi,Emily Graves,Fiona Fernandes,Zih-Liang Yang,Ian Coldicott,Jennifer Hirst,Christopher P Webster,J Robin Highley,Neil Hackett,Adrienn Angyal,Thushan de Silva,Adrian Higginbottom,Pamela J Shaw,Laura Ferraiuolo,Darius Ebrahimi-Fakhari,Mimoun Azzouz
Spastic paraplegia 47 (SPG47) is a neurological disorder caused by mutations in the adaptor protein complex 4 β1 subunit (AP4B1) gene leading to AP-4 complex deficiency. SPG47 is characterised by progressive spastic paraplegia, global developmental delay, intellectual disability and epilepsy. Gene therapy aimed at restoring functional AP4B1 protein levels is a rational therapeutic strategy to ameliorate
-
A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear import. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-02 Aude Boulay,Emmanuel Quevarec,Isabelle Malet,Giuseppe Nicastro,Célia Chamontin,Suzon Perrin,Corinne Henriquet,Martine Pugnière,Valérie Courgnaud,Mickaël Blaise,Anne-Geneviève Marcelin,Ian A Taylor,Laurent Chaloin,Nathalie J Arhel
HIV-1 capsids cross nuclear pore complexes (NPCs) by engaging with the nuclear import machinery. To identify compounds that inhibit HIV-1 nuclear import, we screened drugs in silico on a three-dimensional model of a CA hexamer bound by Transportin-1 (TRN-1). Among hits, compound H27 inhibited HIV-1 with a low micromolar IC50. Unlike other CA-targeting compounds, H27 did not alter CA assembly or disassembly
-
Mutation in the mitochondrial chaperone TRAP1 leads to autism with more severe symptoms in males. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-27 Małgorzata Rydzanicz,Bozena Kuzniewska,Marta Magnowska,Tomasz Wójtowicz,Aleksandra Stawikowska,Anna Hojka,Ewa Borsuk,Ksenia Meyza,Olga Gewartowska,Jakub Gruchota,Jacek Miłek,Patrycja Wardaszka,Izabela Chojnicka,Ludwika Kondrakiewicz,Dorota Dymkowska,Alicja Puścian,Ewelina Knapska,Andrzej Dziembowski,Rafał Płoski,Magdalena Dziembowska
There is increasing evidence of mitochondrial dysfunction in autism spectrum disorders (ASD), but the causal relationships are unclear. In an ASD patient whose identical twin was unaffected, we identified a postzygotic mosaic mutation p.Q639* in the TRAP1 gene, which encodes a mitochondrial chaperone of the HSP90 family. Additional screening of 176 unrelated ASD probands revealed an identical TRAP1
-
Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer types. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-01 Hung-Chang Chen,Nico Mueller,Katherine Stott,Chrysa Kapeni,Eilidh Rivers,Carolin M Sauer,Flavio Beke,Stephen J Walsh,Nicola Ashman,Louise O'Brien,Amir Rafati Fard,Arman Ghodsinia,Changtai Li,Fadwa Joud,Olivier Giger,Inti Zlobec,Ioana Olan,Sarah J Aitken,Matthew Hoare,Richard Mair,Eva Serrao,James D Brenton,Alicia Garcia-Gimenez,Simon E Richardson,Brian Huntly,David R Spring,Mikkel-Ole Skjoedt,Karsten
-
RIG-I is an intracellular checkpoint that limits CD8+ T-cell antitumour immunity. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-25 Xiaobing Duan,Jiali Hu,Yuncong Zhang,Xiaoguang Zhao,Mingqi Yang,Taoping Sun,Siya Liu,Xin Chen,Juan Feng,Wenting Li,Ze Yang,Yitian Zhang,Xiaowen Lin,Dingjie Liu,Ya Meng,Guang Yang,Qiuping Lin,Guihai Zhang,Haihong Lei,Zhengsheng Yi,Yanyan Liu,Xiaobing Liang,Yujuan Wu,Wenqing Diao,Zesong Li,Haihai Liang,Meixiao Zhan,Hong-Wei Sun,Xian-Yang Li,Ligong Lu
Retinoic acid-inducible gene I (RIG-I) is a pattern recognition receptor involved in innate immunity, but its role in adaptive immunity, specifically in the context of CD8+ T-cell antitumour immunity, remains unclear. Here, we demonstrate that RIG-I is upregulated in tumour-infiltrating CD8+ T cells, where it functions as an intracellular checkpoint to negatively regulate CD8+ T-cell function and limit
-
Infection length and host environment influence on Plasmodium falciparum dry season reservoir. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-16 Carolina M Andrade,Manuela Carrasquilla,Usama Dabbas,Jessica Briggs,Hannah van Dijk,Nikolay Sergeev,Awa Sissoko,Moussa Niangaly,Christina Ntalla,Emily LaVerriere,Jeff Skinner,Klara Golob,Jeremy Richter,Hamidou Cisse,Shanping Li,Jason A Hendry,Muhammad Asghar,Didier Doumtabe,Anna Farnert,Thomas Ruppert,Daniel E Neafsey,Kassoum Kayentao,Safiatou Doumbo,Aissata Ongoiba,Peter D Crompton,Boubacar Traore
Persistence of malaria parasites in asymptomatic hosts is crucial in areas of seasonally-interrupted transmission, where P. falciparum bridges wet seasons months apart. During the dry season, infected erythrocytes exhibit extended circulation with reduced cytoadherence, increasing the risk of splenic clearance of infected cells and hindering parasitaemia increase. However, what determines parasite
-
Whole-sporozoite malaria vaccines: where we are, where we are going. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-16 Diana Moita,Miguel Prudêncio
The malaria vaccination landscape has seen significant advancements with the recent endorsement of RTS,S/AS01 and R21/Matrix-M vaccines, which target the pre-erythrocytic stages of Plasmodium falciparum (Pf) infection. However, several challenges remain to be addressed, including the incomplete protection afforded by these vaccines, their dependence on a single Pf antigen, and the fact that they were
-
7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectively. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-16 Kishan Kumar Gaur,Tejeswara Rao Asuru,Mitul Srivastava,Nitu Singh,Nikil Purushotham,Boja Poojary,Bhabatosh Das,Sankar Bhattacharyya,Shailendra Asthana,Prasenjit Guchhait
There are a limited number of effective vaccines against dengue virus (DENV) and significant efforts are being made to develop potent anti-virals. Previously, we described that platelet-chemokine CXCL4 negatively regulates interferon (IFN)-α/β synthesis and promotes DENV2 replication. An antagonist to CXCR3 (CXCL4 receptor) reversed it and inhibited viral replication. In a concurrent search, we identified
-
ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-13 Chiara Pozzato,Gonçalo Outeiro-Pinho,Mirco Galiè,Giorgio Ramadori,Georgia Konstantinidou
Mutated KRAS serves as the oncogenic driver in 30% of non-small cell lung cancers (NSCLCs) and is associated with metastatic and therapy-resistant tumors. Focal Adhesion Kinase (FAK) acts as a mediator in sustaining KRAS-driven lung tumors, and although FAK inhibitors are currently undergoing clinical development, clinical data indicated that their efficacy in producing long-term anti-tumor responses
-
CRISPR-enabled point-of-care genotyping for APOL1 genetic risk assessment. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-13 Robert Greensmith,Isadora T Lape,Cristian V Riella,Alexander J Schubert,Jakob J Metzger,Anand S Dighe,Xiao Tan,Bernhard Hemmer,Josefine Rau,Sarah Wendlinger,Nora Diederich,Anja Schütz,Leonardo V Riella,Michael M Kaminski
Detecting genetic variants enables risk factor identification, disease screening, and initiation of preventative therapeutics. However, current methods, relying on hybridization or sequencing, are unsuitable for point-of-care settings. In contrast, CRISPR-based-diagnostics offer high sensitivity and specificity for point-of-care applications. While these methods have predominantly been used for pathogen
-
Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn's disease. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-13 Xuehua Li,Shixian Hu,Xiaodi Shen,Ruonan Zhang,Caiguang Liu,Lin Xiao,Jinjiang Lin,Li Huang,Weitao He,Xinyue Wang,Lili Huang,Qingzhu Zheng,Luyao Wu,Canhui Sun,Zhenpeng Peng,Minhu Chen,Ziping Li,Rui Feng,Yijun Zhu,Yangdi Wang,Zhoulei Li,Ren Mao,Shi-Ting Feng
Intestinal fibrosis is the primary cause of disability in patients with Crohn's disease (CD), yet effective therapeutic strategies are currently lacking. Here, we report a multiomics analysis of gut microbiota and fecal/blood metabolites of 278 CD patients and 28 healthy controls, identifying characteristic alterations in gut microbiota (e.g., Lachnospiraceae, Ruminococcaceae, Muribaculaceae, Saccharimonadales)
-
An intrinsic mechanism of metabolic tuning promotes cardiac resilience to stress. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-13 Matteo Sorge,Giulia Savoré,Andrea Gallo,Davide Acquarone,Mauro Sbroggiò,Silvia Velasco,Federica Zamporlini,Saveria Femminò,Enrico Moiso,Giampaolo Morciano,Elisa Balmas,Andrea Raimondi,Gabrielle Nattenberg,Rachele Stefania,Carlo Tacchetti,Angela Maria Rizzo,Paola Corsetto,Alessandra Ghigo,Emilia Turco,Fiorella Altruda,Lorenzo Silengo,Paolo Pinton,Nadia Raffaelli,Nathan J Sniadecki,Claudia Penna,Pasquale
Defining the molecular mechanisms underlying cardiac resilience is crucial to find effective approaches to protect the heart. A physiologic level of ROS is produced in the heart by fatty acid oxidation, but stressful events can boost ROS and cause mitochondrial dysfunction and cardiac functional impairment. Melusin is a muscle specific chaperone required for myocardial compensatory remodeling during
-
Trained immunity of intestinal tuft cells during infancy enhances host defense against enteroviral infections in mice. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-11 Deyan Chen,Jing Wu,Fang Zhang,Ruining Lyu,Qiao You,Yajie Qian,Yurong Cai,Xiaoyan Tian,Hongji Tao,Yating He,Waqas Nawaz,Zhiwei Wu
Innate immune cells have been acknowledged as trainable in recent years. While intestinal tuft cells are recognized for their crucial roles in the host defense against intestinal pathogens, there remains uncertainty regarding their trainability. Enterovirus 71 (EV71), a prevalent enterovirus that primarily infects children but rarely infects adults. At present, there is a significant expansion of intestinal
-
A critical role for HNF4α in polymicrobial sepsis-associated metabolic reprogramming and death. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-11 Céline Van Dender,Steven Timmermans,Ville Paakinaho,Tineke Vanderhaeghen,Jolien Vandewalle,Maarten Claes,Bruno Garcia,Bart Roman,Jan De Waele,Siska Croubels,Karolien De Bosscher,Philip Meuleman,Antoine Herpain,Jorma J Palvimo,Claude Libert
In sepsis, limited food intake and increased energy expenditure induce a starvation response, which is compromised by a quick decline in the expression of hepatic PPARα, a transcription factor essential in intracellular catabolism of free fatty acids. The mechanism upstream of this PPARα downregulation is unknown. We found that sepsis causes a progressive hepatic loss-of-function of HNF4α, which has
-
The influence of AHR on immune and tissue biology. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-06 Brigitta Stockinger,Oscar E Diaz,Emma Wincent
The aryl hydrocarbon receptor is a ligand dependent transcription factor which functions as an environmental sensor. Originally discovered as the sensor for man made pollutants such as 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) it has recently gained prominence as an important mediator for environmental triggers via the diet or microbiota which influences many physiological functions in different cell
-
Next generation of "magic bullets", solutions from the microbial pangenome. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-06 Vega Masignani,Rino Rappuoli,Mariagrazia Pizza
-
Can we manipulate the ovary's own metabolism to protect it from chemotherapy-induced damage? EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-03 Adomas Liugaila,Agnes Stefansdottir,Norah Spears
-
The gray boundaries of aberrant shortening of the cellular timekeepers' edges. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-28 Guillermo Guenechea,Nestor W Meza
-
The evolving genetic landscape of telomere biology disorder dyskeratosis congenita. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-28 Hemanth Tummala,Amanda J Walne,Mohsin Badat,Manthan Patel,Abigail M Walne,Jenna Alnajar,Chi Ching Chow,Ibtehal Albursan,Jennifer M Frost,David Ballard,Sally Killick,Peter Szitányi,Anne M Kelly,Manoj Raghavan,Corrina Powell,Reinier Raymakers,Tony Todd,Elpis Mantadakis,Sophia Polychronopoulou,Nikolas Pontikos,Tianyi Liao,Pradeep Madapura,Upal Hossain,Tom Vulliamy,Inderjeet Dokal
Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome, caused by genetic mutations that principally affect telomere biology. Approximately 35% of cases remain uncharacterised at the genetic level. To explore the genetic landscape, we conducted genetic studies on a large collection of clinically diagnosed cases of DC as well as cases exhibiting features resembling DC, referred
-
Human breast tissue engineering in health and disease. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-23 Maj-Britt Buchholz,Demi I Scheerman,Riccardo Levato,Ellen J Wehrens,Anne C Rios
The human mammary gland represents a highly organized and dynamic tissue, uniquely characterized by postnatal developmental cycles. During pregnancy and lactation, it undergoes extensive hormone-stimulated architectural remodeling, culminating in the formation of specialized structures for milk production to nourish offspring. Moreover, it carries significant health implications, due to the high prevalence
-
Novel immunotherapeutics against LGR5 to target multiple cancer types. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-21 Hung-Chang Chen,Nico Mueller,Katherine Stott,Chrysa Kapeni,Eilidh Rivers,Carolin M Sauer,Flavio Beke,Stephen J Walsh,Nicola Ashman,Louise O'Brien,Amir Rafati Fard,Arman Ghodsinia,Changtai Li,Fadwa Joud,Olivier Giger,Inti Zlobec,Ioana Olan,Sarah J Aitken,Matthew Hoare,Richard Mair,Eva Serrao,James D Brenton,Alicia Garcia-Gimenez,Simon E Richardson,Brian Huntly,David R Spring,Mikkel-Ole Skjoedt,Karsten
We have developed and validated a highly specific, versatile antibody to the extracellular domain of human LGR5 (α-LGR5). α-LGR5 detects LGR5 overexpression in >90% of colorectal cancer (CRC), hepatocellular carcinoma (HCC) and pre-B-ALL tumour cells and was used to generate an Antibody-Drug Conjugate (α-LGR5-ADC), Bispecific T-cell Engager (α-LGR5-BiTE) and Chimeric Antigen Receptor (α-LGR5-CAR).
-
Fertility protection during chemotherapy treatment by boosting the NAD(P)+ metabolome. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-21 Wing-Hong Jonathan Ho,Maria B Marinova,Dave R Listijono,Michael J Bertoldo,Dulama Richani,Lynn-Jee Kim,Amelia Brown,Angelique H Riepsamen,Safaa Cabot,Emily R Frost,Sonia Bustamante,Ling Zhong,Kaisa Selesniemi,Derek Wong,Romanthi Madawala,Maria Marchante,Dale M Goss,Catherine Li,Toshiyuki Araki,David J Livingston,Nigel Turner,David A Sinclair,Kirsty A Walters,Hayden A Homer,Robert B Gilchrist,Lindsay
Chemotherapy induced ovarian failure and infertility is an important concern in female cancer patients of reproductive age or younger, and non-invasive, pharmacological approaches to maintain ovarian function are urgently needed. Given the role of reduced nicotinamide adenine dinucleotide phosphate (NADPH) as an essential cofactor for drug detoxification, we sought to test whether boosting the NAD(P)+
-
Restoration of defective oxidative phosphorylation to a subset of neurons prevents mitochondrial encephalopathy. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-21 Brittni R Walker,Lise-Michelle Theard,Milena Pinto,Monica Rodriguez-Silva,Sandra R Bacman,Carlos T Moraes
Oxidative Phosphorylation (OXPHOS) defects can cause severe encephalopathies and no effective treatment exists for these disorders. To assess the ability of gene replacement to prevent disease progression, we subjected two different CNS-deficient mouse models (Ndufs3/complex I or Cox10/complex IV conditional knockouts) to gene therapy. We used retro-orbitally injected AAV-PHP.eB to deliver the missing
-
Immunotherapies targeting the oncogenic fusion gene CLDN18-ARHGAP in gastric cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-20 Yue Wang,Hanbing Wang,Tao Shi,Xueru Song,Xin Zhang,Yue Zhang,Xuan Wang,Keying Che,Yuting Luo,Lixia Yu,Baorui Liu,Jia Wei
The CLDN18-ARHGAP fusion gene is an oncogenic driver newly discovered in gastric cancer. It was detected in 9% (8/87) of gastric cancer patients in our center. An immunogenic peptide specifically targeting CLDN18-ARHGAP fusion gene was generated to induce neoantigen-reactive T cells, which was proved to have specific and robust anti-tumor capacity both in in vitro coculture models and in vivo xenograft
-
An enhanced intracellular delivery platform based on a distant diphtheria toxin homolog that evades pre-existing antitoxin antibodies. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-19 Shivneet K Gill,Seiji N Sugiman-Marangos,Greg L Beilhartz,Elizabeth Mei,Mikko Taipale,Roman A Melnyk
Targeted intracellular delivery of therapeutic proteins remains a significant unmet challenge in biotechnology. A promising approach is to leverage the intrinsic capabilities of bacterial toxins like diphtheria toxin (DT) to deliver a potent cytotoxic enzyme into cells with an associated membrane translocation moiety. Despite showing promising clinical efficacy, widespread deployment of DT-based therapeutics
-
Histidine-rich glycoprotein modulates neutrophils and thrombolysis-associated hemorrhagic transformation. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-15 Wei Jiang,Yuexin Zhao,Rongrong Liu,Bohao Zhang,Yuhan Xie,Bin Gao,Kaibin Shi,Ming Zou,Dongmei Jia,Jiayue Ding,Xiaowei Hu,Yanli Duan,Ranran Han,DeRen Huang,Luc Van Kaer,Fu-Dong Shi
Intravenous thrombolysis using recombinant tissue plasminogen activator (tPA) remains the primary treatment for patients with acute ischemic stroke (AIS). However, the mechanism of tPA-related hemorrhagic transformation (HT) remains poorly understood. Elevation of histidine-rich glycoprotein (HRG) expression was detected by nano-liquid chromatography tandem mass spectrometry at 1 h following tPA infusion
-
Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-09 Peiyong Guan,Jianfeng Chen,Chengqiang Mo,Tomoya Fukawa,Chao Zhang,Xiuyu Cai,Mei Li,Jing Han Hong,Jason Yongsheng Chan,Cedric Chuan Young Ng,Jing Yi Lee,Suet Far Wong,Wei Liu,Xian Zeng,Peili Wang,Rong Xiao,Vikneswari Rajasegaran,Swe Swe Myint,Abner Ming Sun Lim,Joe Poh Sheng Yeong,Puay Hoon Tan,Choon Kiat Ong,Tao Xu,Yiqing Du,Fan Bai,Xin Yao,Bin Tean Teh,Jing Tan
Collecting duct carcinoma (CDC) is an aggressive rare subtype of kidney cancer with unmet clinical needs. Little is known about its underlying molecular alterations and etiology, primarily due to its rarity, and lack of preclinical models. This study aims to comprehensively characterize molecular alterations in CDC and identify its therapeutic vulnerabilities. Through whole-exome and transcriptome
-
Inhibition of GSK3α,β rescues cognitive phenotypes in a preclinical mouse model of CTNNB1 syndrome. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-05 Jonathan M Alexander,Leeanne Vazquez-Ramirez,Crystal Lin,Pantelis Antonoudiou,Jamie Maguire,Florence Wagner,Michele H Jacob
CTNNB1 syndrome is a rare monogenetic disorder caused by CTNNB1 de novo pathogenic heterozygous loss-of-function variants that result in cognitive and motor disabilities. Treatment is currently lacking; our study addresses this critical need. CTNNB1 encodes β-catenin which is essential for normal brain function via its dual roles in cadherin-based synaptic adhesion complexes and canonical Wnt signal
-
The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-05 Jinhai Deng,Teng Pan,Dan Wang,Yourae Hong,Zaoqu Liu,Xingang Zhou,Zhengwen An,Lifeng Li,Giovanna Alfano,Gang Li,Luigi Dolcetti,Rachel Evans,Jose M Vicencio,Petra Vlckova,Yue Chen,James Monypenny,Camila Araujo De Carvalho Gomes,Gregory Weitsman,Kenrick Ng,Caitlin McCarthy,Xiaoping Yang,Zedong Hu,Joanna C Porter,Christopher J Tape,Mingzhu Yin,Fengxiang Wei,Manuel Rodriguez-Justo,Jin Zhang,Sabine Tejpar
Chemotherapy, the standard of care treatment for cancer patients with advanced disease, has been increasingly recognized to activate host immune responses to produce durable outcomes. Here, in colorectal adenocarcinoma (CRC) we identify oxaliplatin-induced Thioredoxin-Interacting Protein (TXNIP), a MondoA-dependent tumor suppressor gene, as a negative regulator of Growth/Differentiation Factor 15 (GDF15)
-
Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-31 Hong Wang,Huizi Sun,Jie Huang,Zhenhua Zhang,Guodi Cai,Chaofan Wang,Kai Xiao,Xiaofeng Xiong,Jian Zhang,Peiqing Liu,Xiaoyun Lu,Weineng Feng,Junjian Wang
Small-cell lung cancer (SCLC) is the most aggressive and lethal type of lung cancer, characterized by limited treatment options, early and frequent metastasis. However, the determinants of metastasis in SCLC are poorly defined. Here, we show that estrogen-related receptor gamma (ERRγ) is overexpressed in metastatic SCLC tumors, and is positively associated with SCLC progression. ERRγ functions as an
-
The RhoB p.S73F mutation leads to cerebral palsy through dysregulation of lipid homeostasis. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-30 Xinyu Wu,Ruonan Liu,Zhongtian Zhang,Jie Yang,Xin Liu,Liqiang Jiang,Mengmeng Fang,Shoutang Wang,Liangxue Lai,Yuning Song,Zhanjun Li
Cerebral palsy (CP) is a prevalent neurological disorder that imposes a significant burden on children, families, and society worldwide. Recently, the RhoB p.S73F mutation was identified as a de novo mutation associated with CP. However, the mechanism by which the RhoB p.S73F mutation causes CP is currently unclear. In this study, rabbit models were generated to mimic the human RhoB p.S73F mutation
-
"Cruising together"-ASC specks and SAA, a perfect match in chronic inflammation. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-30 Salie Maasewerd,Bernardo Simoes Franklin
-
The ASC inflammasome adapter governs SAA-derived protein aggregation in inflammatory amyloidosis. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-30 Marco Losa,Marc Emmenegger,Pierre De Rossi,Patrick M Schürch,Tetiana Serdiuk,Niccolò Pengo,Danaëlle Capron,Dimitri Bieli,Niklas Bargenda,Niels J Rupp,Manfredi C Carta,Karl J Frontzek,Veronika Lysenko,Regina R Reimann,Petra Schwarz,Mario Nuvolone,Gunilla T Westermark,K Peter R Nilsson,Magdalini Polymenidou,Alexandre Pa Theocharides,Simone Hornemann,Paola Picotti,Adriano Aguzzi
Extracellularly released molecular inflammasome assemblies -ASC specks- cross-seed Aβ amyloid in Alzheimer's disease. Here we show that ASC governs the extent of inflammation-induced amyloid A (AA) amyloidosis, a systemic disease caused by the aggregation and peripheral deposition of the acute-phase reactant serum amyloid A (SAA) in chronic inflammatory conditions. Using super-resolution microscopy
-
Dantrolene corrects cellular disease features of Darier disease and may be a novel treatment. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-26 Matthew Hunt,Nuoqi Wang,Naricha Pupinyo,Philip Curman,Monica Torres,William Jebril,Maria Chatzinikolaou,Julie Lorent,Gilad Silberberg,Ritu Bansal,Teresa Burner,Jing Zhou,Susanne Kimeswenger,Wolfram Hoetzenecker,Keith Choate,Etty Bachar-Wikstrom,Jakob D Wikstrom
Darier disease (DD) is a rare severe acantholytic skin disease caused by mutations in the ATP2A2 gene that encodes for the sarco/endoplasmic reticulum calcium ATPase isoform 2 (SERCA2). SERCA2 maintains endoplasmic reticulum calcium homeostasis by pumping calcium into the ER, critical for regulating cellular calcium dynamics and cellular function. To date, there is no treatment that specifically targets
-
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-19 Luisa Chocarro,Ester Blanco,Leticia Fernandez-Rubio,Maider Garnica,Miren Zuazo,Maria Jesus Garcia,Ana Bocanegra,Miriam Echaide,Colette Johnston,Carolyn J Edwards,James Legg,Andrew J Pierce,Hugo Arasanz,Gonzalo Fernandez-Hinojal,Ruth Vera,Karina Ausin,Enrique Santamaria,Joaquin Fernandez-Irigoyen,Grazyna Kochan,David Escors
Many cancer patients do not benefit from PD-L1/PD-1 blockade immunotherapies. PD-1 and LAG-3 co-upregulation in T-cells is one of the major mechanisms of resistance by establishing a highly dysfunctional state in T-cells. To identify shared features associated to PD-1/LAG-3 dysfunctionality in human cancers and T-cells, multiomic expression profiles were obtained for all TCGA cancers immune infiltrates
-
LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-19 Jing Wang,Qiyao Chai,Zehui Lei,Yiru Wang,Jiehua He,Pupu Ge,Zhe Lu,Lihua Qiang,Dongdong Zhao,Shanshan Yu,Changgen Qiu,Yanzhao Zhong,Bing-Xi Li,Lingqiang Zhang,Yu Pang,George Fu Gao,Cui Hua Liu
Chronic infections, including Mycobacterium tuberculosis (Mtb)-caused tuberculosis (TB), can induce host immune exhaustion. However, the key checkpoint molecules involved in this process and the underlying regulatory mechanisms remain largely undefined, which impede the application of checkpoint-based immunotherapy in infectious diseases. Here, through adopting time-of-flight mass cytometry and transcriptional
-
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-15 Jeremy Rich,Melanie Bennaroch,Laura Notel,Polina Patalakh,Julien Alberola,Fayez Issa,Paule Opolon,Olivia Bawa,Windy Rondof,Antonin Marchais,Philippe Dessen,Guillaume Meurice,Morgane Le-Gall,Melanie Polrot,Karine Ser-Le Roux,Kamel Mamchaoui,Nathalie Droin,Hana Raslova,Pascal Maire,Birgit Geoerger,Iryna Pirozhkova
We have recently identified the uncharacterized ZNF555 protein as a component of a productive complex involved in the morbid function of the 4qA locus in facioscapulohumeral dystrophy. Subsequently named DiPRO1 (Death, Differentiation, and PROliferation related PROtein 1), our study provides substantial evidence of its role in the differentiation and proliferation of human myoblasts. DiPRO1 operates
-
Immune-enhancing neutrophils reprogrammed by subclinical low-dose endotoxin in cancer treatment. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-15 Yao Zhang,Christina Lee,Shuo Geng,Jing Wang,Udipta Bohara,Jacqueline Hou,Ziyue Yi,Liwu Li
Despite the re-emergence of the pioneering "Coley's toxin" concept in anti-cancer immune therapies highlighted by check-point inhibitors and CAR-T approaches, fundamental mechanisms responsible for the immune-enhancing efficacy of low-dose "Coley's toxin" remain poorly understood. This study examines the novel reprogramming of immune-enhancing neutrophils by super-low dose endotoxin conducive for anti-cancer
-
In vitro and in vivo inhibition of the host TRPC4 channel attenuates Zika virus infection. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-15 Xingjuan Chen,Yunzheng Yan,Zhiqiang Liu,Shaokang Yang,Wei Li,Zhuang Wang,Mengyuan Wang,Juan Guo,Zhenyang Li,Weiyan Zhu,Jingjing Yang,Jiye Yin,Qingsong Dai,Yuexiang Li,Cui Wang,Lei Zhao,Xiaotong Yang,Xiaojia Guo,Ling Leng,Jiaxi Xu,Alexander G Obukhov,Ruiyuan Cao,Wu Zhong
Zika virus (ZIKV) infection may lead to severe neurological consequences, including seizures, and early infancy death. However, the involved mechanisms are still largely unknown. TRPC channels play an important role in regulating nervous system excitability and are implicated in seizure development. We investigated whether TRPCs might be involved in the pathogenesis of ZIKV infection. We found that
-
Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-08 Alexander Seidinger,Richard Roberts,Yan Bai,Marion Müller,Eva Pfeil,Michaela Matthey,Sarah Rieck,Judith Alenfelder,Gabriele M König,Alexander Pfeifer,Evi Kostenis,Anna Klinke,Bernd K Fleischmann,Daniela Wenzel
Pulmonary arterial hypertension (PAH) is a life-threatening disease with limited survival. Herein, we propose the pharmacological inhibition of Gq proteins as a novel concept to counteract pulmonary vasoconstriction and proliferation/migration of pulmonary artery smooth muscle cells (PASMCs) in PAH. We demonstrate that the specific pan-Gq inhibitor FR900359 (FR) induced a strong vasorelaxation in large
-
Platelet transcription factors license the pro-inflammatory cytokine response of human monocytes. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-08 Ibrahim Hawwari,Lukas Rossnagel,Nathalia Rosero,Salie Maasewerd,Matilde B Vasconcelos,Marius Jentzsch,Agnieszka Demczuk,Lino L Teichmann,Lisa Meffert,Damien Bertheloot,Lucas S Ribeiro,Sebastian Kallabis,Felix Meissner,Moshe Arditi,Asli E Atici,Magali Noval Rivas,Bernardo S Franklin
In humans, blood Classical CD14+ monocytes contribute to host defense by secreting large amounts of pro-inflammatory cytokines. Their aberrant activity causes hyper-inflammation and life-threatening cytokine storms, while dysfunctional monocytes are associated with 'immunoparalysis', a state of immune hypo responsiveness and reduced pro-inflammatory gene expression, predisposing individuals to opportunistic
-
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-02 Yifan Tai,Angela Chow,Seoyoung Han,Courtney Coker,Wanchao Ma,Yifan Gu,Valeria Estrada Navarro,Manoj Kandpal,Hanina Hibshoosh,Kevin Kalinsky,Katia Manova-Todorova,Anton Safonov,Elaine M Walsh,Mark Robson,Larry Norton,Richard Baer,Taha Merghoub,Anup K Biswas,Swarnali Acharyya
Acquired resistance to PARP inhibitors (PARPi) remains a treatment challenge for BRCA1/2-mutant breast cancer that drastically shortens patient survival. Although several resistance mechanisms have been identified, none have been successfully targeted in the clinic. Using new PARPi-resistance models of Brca1- and Bard1-mutant breast cancer generated in-vivo, we identified FLT1 (VEGFR1) as a driver
-
Author Correction: Mediators of necroptosis: from cell death to metabolic regulation. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-01 Xiaoqin Wu,Laura E Nagy,Jérémie Gautheron